| P50 | author | D Allan Butterfield | Q66912067 |
| P2093 | author name string | Susan A Farr | |
| | John E Morley | |
| | M Paul Murphy | |
| | Rukhsana Sultana | |
| | Thomas L Platt | |
| | Michael L Niehoff | |
| | Vijaya Kumar | |
| | Zhaoshu Zhang | |
| | Jessica L Ripley | |
| P2860 | cites work | Structure of the Keap1:Nrf2 interface provides mechanistic insight into Nrf2 signaling | Q24298930 |
| | Primed phosphorylation of tau at Thr231 by glycogen synthase kinase 3beta (GSK3beta) plays a critical role in regulating tau's ability to bind and stabilize microtubules | Q24302556 |
| | Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain | Q24609907 |
| | Glycogen synthase kinase-3 (GSK3): inflammation, diseases, and therapeutics | Q24685475 |
| | Measurement of protein using bicinchoninic acid | Q26778491 |
| | Lithium reduces tau phosphorylation by inhibition of glycogen synthase kinase-3. | Q48622377 |
| | Distribution, levels, and activity of glycogen synthase kinase-3 in the Alzheimer disease brain | Q48822557 |
| | Delivery across the blood-brain barrier of antisense directed against amyloid beta: reversal of learning and memory deficits in mice overexpressing amyloid precursor protein | Q48876526 |
| | Site-directed antisense oligonucleotide decreases the expression of amyloid precursor protein and reverses deficits in learning and memory in aged SAMP8 mice | Q49096995 |
| | Beta-amyloid precursor polypeptide in SAMP8 mice affects learning and memory | Q49097021 |
| | Activation of Akt by lithium: pro-survival pathways in aging. | Q50621066 |
| | Age-related deterioration of ability of acquisition in memory and learning in senescence accelerated mouse: SAM-P/8 as an animal model of disturbances in recent memory. | Q52120589 |
| | Preferential labeling of Alzheimer neurofibrillary tangles with antisera for tau protein kinase (TPK) I/glycogen synthase kinase-3 beta and cyclin-dependent kinase 5, a component of TPK II. | Q53322724 |
| | 2013 Alzheimer's disease facts and figures | Q86421768 |
| | GSK-3alpha regulates production of Alzheimer's disease amyloid-beta peptides | Q28205921 |
| | Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants | Q28218883 |
| | An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements | Q28244853 |
| | Molecular cloning and expression of glycogen synthase kinase-3/factor A | Q28569645 |
| | Distinct Cysteine Residues in Keap1 Are Required for Keap1-Dependent Ubiquitination of Nrf2 and for Stabilization of Nrf2 by Chemopreventive Agents and Oxidative Stress | Q29617845 |
| | Inhibition of GSK3β-mediated BACE1 expression reduces Alzheimer-associated phenotypes | Q30530899 |
| | Testing the neurovascular hypothesis of Alzheimer's disease: LRP-1 antisense reduces blood-brain barrier clearance, increases brain levels of amyloid-beta protein, and impairs cognition | Q33576221 |
| | Regulatory mechanisms of cellular response to oxidative stress | Q33750101 |
| | Judging a protein by more than its name: GSK-3. | Q34093128 |
| | Decreased nuclear beta-catenin, tau hyperphosphorylation and neurodegeneration in GSK-3beta conditional transgenic mice | Q34449486 |
| | Synergistic Interactions between Abeta, tau, and alpha-synuclein: acceleration of neuropathology and cognitive decline | Q35840610 |
| | The many faces of tau | Q35870359 |
| | Selectively silencing GSK-3 isoforms reduces plaques and tangles in mouse models of Alzheimer's disease | Q36012200 |
| | Glycogen synthase kinase 3: a point of integration in Alzheimer's disease and a therapeutic target? | Q36063447 |
| | Activation of the Nrf2-ARE pathway by siRNA knockdown of Keap1 reduces oxidative stress and provides partial protection from MPTP-mediated neurotoxicity | Q36464631 |
| | GSK-3 is essential in the pathogenesis of Alzheimer's disease. | Q36568147 |
| | The GSK3 hypothesis of Alzheimer's disease | Q37035378 |
| | AEG-35156, an antisense oligonucleotide against X-linked inhibitor of apoptosis for the potential treatment of cancer | Q37179130 |
| | From aging to Alzheimer's disease: unveiling "the switch" with the senescence-accelerated mouse model (SAMP8). | Q37354749 |
| | Making sense of therapeutics using antisense technology | Q38014478 |
| | Lipid peroxidation triggers neurodegeneration: a redox proteomics view into the Alzheimer disease brain | Q38050263 |
| | Regulation of gamma-glutamylcysteine synthetase subunit gene expression by the transcription factor Nrf2. | Q38318490 |
| | Coordinate Regulation of Glutathione Biosynthesis and Release by Nrf2-Expressing Glia Potently Protects Neurons from Oxidative Stress | Q38355236 |
| | In vivo P2X7 inhibition reduces amyloid plaques in Alzheimer's disease through GSK3β and secretases. | Q39448933 |
| | Acetylcarnitine induces heme oxygenase in rat astrocytes and protects against oxidative stress: involvement of the transcription factor Nrf2. | Q40473279 |
| | Divergent roles of GSK3 and CDK5 in APP processing | Q40611214 |
| | Alzheimer's disease-like phosphorylation of the microtubule-associated protein tau by glycogen synthase kinase-3 in transfected mammalian cells. | Q41423732 |
| | Learning and memory in the SAMP8 mouse | Q41716293 |
| | Nuclear factor E2-related factor 2-dependent antioxidant response element activation by tert-butylhydroquinone and sulforaphane occurring preferentially in astrocytes conditions neurons against oxidative insult. | Q44755335 |
| | Peripheral administration of antisense oligonucleotides targeting the amyloid-β protein precursor reverses AβPP and LRP-1 overexpression in the aged SAMP8 mouse brain | Q44777555 |
| | Quantitative proteomics analysis of specific protein expression and oxidative modification in aged senescence-accelerated-prone 8 mice brain | Q44944553 |
| | Antisense directed at the Abeta region of APP decreases brain oxidative markers in aged senescence accelerated mice | Q44985177 |
| | A novel GSK-3beta inhibitor reduces Alzheimer's pathology and rescues neuronal loss in vivo. | Q45970893 |
| | Preproenkephalin targeted antisenses cross the blood-brain barrier to reduce brain methionine enkephalin levels and increase voluntary ethanol drinking | Q46757070 |
| | Distribution of active glycogen synthase kinase 3beta (GSK-3beta) in brains staged for Alzheimer disease neurofibrillary changes | Q48105061 |
| | Lithium protects cultured neurons against beta-amyloid-induced neurodegeneration | Q48163930 |
| | Increased level of active GSK-3beta in Alzheimer's disease and accumulation in argyrophilic grains and in neurones at different stages of neurofibrillary degeneration | Q48303820 |
| | Chronic lithium administration to FTDP-17 tau and GSK-3beta overexpressing mice prevents tau hyperphosphorylation and neurofibrillary tangle formation, but pre-formed neurofibrillary tangles do not revert. | Q48389526 |
| | Glycogen synthase kinase-3 induces Alzheimer's disease-like phosphorylation of tau: generation of paired helical filament epitopes and neuronal localisation of the kinase | Q48406074 |
| | Lipid peroxidation in brain during aging in the senescence-accelerated mouse (SAM). | Q48469494 |
| | On the delay-dependent involvement of the hippocampus in object recognition memory | Q48542116 |
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P921 | main subject | Alzheimer's disease | Q11081 |
| P304 | page(s) | 387-395 | |
| P577 | publication date | 2013-12-16 | |
| P1433 | published in | Free Radical Biology and Medicine | Q5500023 |
| P1476 | title | Antisense oligonucleotide against GSK-3β in brain of SAMP8 mice improves learning and memory and decreases oxidative stress: Involvement of transcription factor Nrf2 and implications for Alzheimer disease | |
| P478 | volume | 67 | |